Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | BXBL | IBP |
|---|---|---|
| Price | $3.28 | $184.40 |
| Change today | ▲ 0.15% | ▼ 4.38% |
| Market cap | $792.10M | $4.90B |
| Return, 3 months | -67.3% | -16.0% |
| Return, year to date | -67.3% | -28.1% |
| Return, 1 year | -67.2% | -23.2% |
| P/E (TTM) | -13.7 | 19.9 |
| P/B | 9.0 | 7.7 |
| P/E percentile vs own 5y | 91st | 43rd |
| Dividend yield | – | 1.80% |
| Revenue growth (YoY, latest qtr) | +77.4% | +2.3% |
| Net profit growth (YoY) | +68.8% | -5.9% |
| Gross margin | -365.9% | 33.6% |
| Operating margin | -1,092.2% | 12.4% |
| Net margin | -1,064.4% | 8.5% |
| Return on equity | – | 38.5% |
| Analyst target vs. price | – | +34.2% |
| Analyst buy share | – | 33% |
| RSI (14) | 29 | 31 |
| 30-day volatility | 61.3% | 41.1% |
| Max drawdown, 1 year | -78.4% | -45.8% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
